Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). (Q44558738)

4 December 2017

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). (English)

1 reference

4 December 2017

0 references

0 references

ventricular dysfunction

1 reference

left ventricular dysfunction

inferred from title

1 reference

3

Bertram Pitt

1 reference

4 December 2017

Michael Domanski

1

1 reference

4 December 2017

James Norman

2

1 reference

4 December 2017

Mark Haigney

4

1 reference

4 December 2017

Stephen Hanlon

5

1 reference

4 December 2017

Eliot Peyster

6

1 reference

4 December 2017

Studies of Left Ventricular Dysfunction

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

1 reference

4 December 2017

42

1 reference

4 December 2017

4

1 reference

4 December 2017

705-708

1 reference

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Aldosterone and antialdosterone therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Neurohormonal interactions and adaptations in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Chronic administration of aldosterone depresses baroreceptor reflex function in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Hormones and the pathogenesis of congestive heart failure: vasopressin, aldosterone, and angiotensin II. Further evidence for renal-adrenal interaction from studies in hypertension and in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Captopril in heart failure. A double blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Antihypertensive Therapy with MK 4211

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

The effects of chronic hepatic venous congestion on the metabolism of d,1-aldosterone and d-aldosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

SPLANCHNIC EXTRACTION AND CLEARANCE OF ALDOSTERONE IN SUBJECTS WITH MINIMAL AND MARKED CARDIAC DYSFUNCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Aldosterone and spironolactone in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900765-4

7 January 2021

10.1016/S0735-1097(03)00765-4

Identifiers

DOI

1 reference

4 December 2017

1 reference